youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
US$153,43
arrow_downward
-8,99%(-15,15) 1D
US$137,49
arrow_downward
-10,39% (-15,94)bedtimeAfter hours
Closed: 5 ພ.ຈ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$165,00
High
US$165,10
Low
US$151,92
Mkt. cap
20,59 ຕື້
Avg. vol.
1,81 ລ້ານ
Volume
0,00
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$165,00
High
US$165,10
Low
US$151,92
Mkt. cap
20,59 ຕື້
Avg. vol.
1,81 ລ້ານ
Volume
0,00
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
6 ຊົ່ວໂມງກ່ອນ
What Guardant Health (GH) Said on Its Q3 Earnings Call
GenomeWeb
·
7 ຊົ່ວໂມງກ່ອນ
Guardant Health Q3 Revenue Climbs 36 Percent as Firm Raises Full-Year Guidance
Zacks
·
8 ຊົ່ວໂມງກ່ອນ
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Securities.io
·
8 ຊົ່ວໂມງກ່ອນ
Guardant Health Lifts 2026 Revenue Outlook as Screening Surges
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com